Alcohol
Volume 20, Issue 3 , Pages 293-304 , April 2000

Gamma-hydroxybutyric acid and growth hormone secretion Studies in rats and dogs

Received 21 January 1999 ,Accepted 27 January 1999.

References 

  1. Arce V, Cella SG, Loche S, Ghigo E, Devesa J, Müller EE. Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs. Brain Res. 1990;537:359–362
  2. Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog Neurobiol. 1989;33:399–447
  3. Bernasconi R, Lauber J, Marescaux C, Vergnes M, Martin P, Rubio V, et al. Experimental absence seizures (potential role of gamma-hydroxybutyric acid and GABAB receptors). J Neural Transm. 1992;35(suppl.):155–177
  4. Cella SG, Locatelli V, De Gennaro V, Wehrenberg WB, Müller EE. Pharmacological manipulations of α-adrenoceptors in the infant rat and effects on growth hormone secretion (study of the underlying mechanisms of action). Endocrinology. 1987;120:1639–1643
  5. Cella SG, Locatelli V, De Gennaro V, Bondiolotti GP, Pintor C, Loche S, et al. Epinephrine mediates the growth hormone-releasing effect of galanin in infant rats. Endocrinology. 1988;122:855–859
  6. Cella SG, Locatelli V, Broccia ML, Menegola E, Giavini E, De Gennaro Colonna V, et al. Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat. J Endocrinol. 1994;140:111–117
  7. Cella SG, Locatelli V, Poratelli M, De Gennaro Colonna V, Imbimbo BP, Deghenghi R, et al. Hexarelin, a potent GHRP analogue (interactions with GHRH and clonidine in young and aged dogs). Peptides. 1995;16:81–86
  8. Davis LL, Trivedi M, Kramer GL, Rush AJ, Orsulak PJ, Akers L, et al. Growth hormone response to baclofen (a comparison of 10-mg and 20-mg doses in healthy men). Psychiatry Res. 1996;60:41–47
  9. Engberg G, Nissbrandt H. Gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors. Naunyn-Schmiedebergs Arch Pharmacol. 1993;348:491–497
  10. Froestl W, Mickel SJ, von Sprecher G, Diel PJ, Hall RG, Maier L, et al. Phosphinic acid analogues of GABA 2 (selective, orally active GABAB antagonists). J Med Chem. 1995;38:3313–3331
  11. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet. 1989;2:787–789
  12. Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate (an emerging drug of abuse that causes physical dependence). Addiction. 1997;92:89–96
  13. Gerra G, Caccavari R, Fontanesi B, Marcato A, Fertonani Affini G, Maestri D, et al. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol. 1994;9:211–215
  14. Gerra G, Caccavari R, Fontanesi B, Fertonani Affini G, Maestri D, Avanzini P, et al. Naloxone and metergoline effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol. 1995;10:245–250
  15. Gessa GL. Guida al trattamento farmacologico dell'alcolismo. Recenti Prog Med. 1990;81:171–175
  16. Grilli R, Ghigo MC, Torsello A, Guidi M, Luoni M, Locatelli V, et al. Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels II (a study in the infant rat). J Endocrinol Invest. 1997;20:151–154
  17. Iven VG. Recreational drugs. Clin Sports Med. 1998;17:245–259
  18. Koulu M, Lammintausta R, Dahlstrom S. Stimulatory effect of acute baclofen administration on human growth hormone secretion. J Clin Endocrinol Metab. 1979;48:1038–1040
  19. Locatelli V, Torsello A. Growth hormone secretagogues (focus on the growth hormone-releasing peptides). Pharmacol Res. 1997;36:415–423
  20. Locatelli V, Grilli R, Torsello A, Cella SG, Wehrenberg WB, Müller EE. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat. Pediatr Res. 1994;36:169–174
  21. Maitre M. The gamma-hydroxybutyrate signalling system in brain (organization and functional implications). Prog Neurobiol. 1997;51:337–361
  22. Maitre M, Hechler V, Vayer P, Gobaille S, Cash CD, Schmitt M, et al. A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther. 1990;255:657–663
  23. Müller EE. Neural control of somatotropic function. Physiol Rev. 1987;67:962–1053
  24. Müller EE, Nisticò G. Neurotransmitter Regulation of the Anterior Pituitary. San Diego: Academic Press; 1989;
  25. Serra M, Sanna C, Biggio G. Isoniazid, an inhibitor of gabaergic transmission, enhances (3,5S)TPBS in rat cerebral cortex. Eur J Pharmacol. 1989;164:385–388
  26. Serra M, Sanna E, Fadda C, Concas A, Biggio G. Failure of gamma-hydroxybutirate to alter the function of the GABA receptor complex in the rat cerebral cortex. Psychopharmacology. 1991;104:351–355
  27. Snead OC. The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites (relation to the development of experimental absence seizures). Brain Res. 1994;659:147–156
  28. Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 1977;44:1014–1017
  29. Tunnicliff G. Sites of action of gamma-hydroxybutyrate (GHB), a neuroactive drug with abuse potential. J Toxicol Clin Toxicol. 1997;35:581–590
  30. Vescovi PP, Di Gennaro C. Failure of gamma-hydroxybutyric acid to stimulate growth hormone secretion in cocaine addicts. Neuropeptides. 1997;31:459–462
  31. Vjayan E, McCann SM. Effects of intraventricular injection of gamma-aminobutiric acid (GABA) on plasma growth hormone and thyrotropin in conscious ovariectomized rats. Endocrinology. 1978;103:1888–1893
  32. Volpi R, Chiodera P, Caffarra P, Scaglioni A, Saccani A, Coiro V. Different control mechanisms of growth hormone (GH) secretion between gamma-amino- and gamma-hydroxy-butyric acid (neuroendocrine evidence in Parkinson's disease). Psychoneuroendocrinology. 1997;22:531–538
  33. Whitwam JG. Flumazenil (a benzodiazepine antagonist). Br Med J. 1988;297:999–1000

PII: S0741-8329(99)00094-4

Alcohol
Volume 20, Issue 3 , Pages 293-304 , April 2000

Article Tools

* Image Usage & Resolution